Versant Capital Management, Inc Exact Sciences Corp Transaction History
Versant Capital Management, Inc
- $710 Million
- Q3 2025
A detailed history of Versant Capital Management, Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Versant Capital Management, Inc holds 1,196 shares of EXAS stock, worth $77,369. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,196
Previous 169
607.69%
Holding current value
$77,369
Previous $8,000
712.5%
% of portfolio
0.01%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding EXAS
# of Institutions
659Shares Held
158MCall Options Held
1.43MPut Options Held
2.35M-
Capital World Investors Los Angeles, CA18.2MShares$1.18 Billion0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$1.16 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$781 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$777 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$348 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.4B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...